- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 571846, 12 pages
Immune Response to Lipoproteins in Atherosclerosis
1Department of Molecular Immunology, Thrombosis Research Institute, Narayana Hrudayalaya Hospital, 258/A, Bommasandra Industrial Area, Bangalore 560099, India
2Scientific Chairman, Thrombosis Research Institute, London, UK
Received 4 June 2012; Accepted 24 July 2012
Academic Editor: Michael Ibrahim
Copyright © 2012 Sonia Samson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [17 citations]
The following is the list of published articles that have cited the current article.
- Csaba Végh, Zoltán Langmár, Melinda Szerző, Annamária Ágota, Krisztina Marosi, Zoltán Szabolcs, and Zsolt B. Nagy, “Az apolipoprotein E genotípusok összefüggése cardiovascularis betegségek kialakulásával,” Orvosi Hetilap, vol. 153, no. 52, pp. 2070–2076, 2012.
- Heike Zeitler, and Gudrun Ulrich-Merzenich, “The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity,” Expert Opinion On Therapeutic Targets, vol. 17, no. 8, pp. 905–919, 2013.
- Carmine Finelli, Antonella Scalera, and Giovanni Tarantino, “Liver-spleen axis: Intersection between immunity, infections and metabolism,” World Journal Of Gastroenterology, vol. 19, no. 23, pp. 3534–3542, 2013.
- Nadimuthu Vinayagamoorthy, Hae-Jin Hu, Seon-Hee Yim, Seung-Hyun Jung, Jaeseong Jo, and Sun Ha Jee, “New Variants Including ARG1 Polymorphisms Associated with C-Reactive Protein Levels Identified by Genome-Wide Association and Pathway Analysis,” Plos One, vol. 9, no. 4, 2014.
- Mukesh K. Jain, Panjamaporn Sangwung, and Anne Hamik, “Regulation of an Inflammatory Disease Kruppel-Like Factors and Atherosclerosis,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 34, no. 3, pp. 499–508, 2014.
- Andreja Trpkovic, Ivana Resanovic, Julijana Stanimirovic, Djordje Radak, Shaker A. Mousa, Desanka Cenic-Milosevic, Danimir Jevremovic, and Esma R. Isenovic, “Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–16, 2014.
- Vladimir V. Bamm, Danielle K. Lanthier, Erin L. Stephenson, Graham S.T. Smith, and George Harauz, “In vitro study of the direct effect of extracellular hemoglobin on myelin components,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014.
- Eliana C. Portilla, Wilson Muñoz, and Carlos H. Sierra, “Mecanismos celulares y moleculares de la aterotrombosis,” Revista Colombiana de Cardiología, vol. 21, no. 1, pp. 35–43, 2014.
- Marta Masztalewicz, Przemyslaw Nowacki, Dariusz Kotlega, Anna Bajer-Czajkowska, and Hanna Drechsler, “Anti-oxLDL antibodies are clinically insignificant for stroke patients,” Neurological Research, vol. 36, no. 1, pp. 86–91, 2014.
- Ronald Klein, Chelsea E. Myers, Kristine E. Lee, Andrew D. Paterson, Karen J. Cruickshanks, Michael Y. Tsai, Ronald E. Gangnon, and Barbara E. K. Klein, “Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fund,” Jama Ophthalmology, vol. 133, no. 9, pp. 1054–1061, 2015.
- Antonio Laguna-Camacho, Arely S. Alonso-Barreto, and Hugo Mendieta-Zerón, “Direct effects of fatty meals and adiposity on oxidised low-density lipoprotein,” Obesity Research & Clinical Practice, 2015.
- Charlotte Spitz, Holger Winkels, Christina Bürger, Christian Weber, Esther Lutgens, Göran K. Hansson, and Norbert Gerdes, “Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential,” Cellular and Molecular Life Sciences, 2015.
- C. O. Hileman, B. Kinley, V. Scharen-Guivel, K. Melbourne, J. Szwarcberg, J. Robinson, M. M. Lederman, and G. A. Mccomsey, “Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals,” Journal of Infectious Diseases, 2015.
- Zhi Xiao Wang, Chong Quan Wang, Xiao Yan Li, Yan Ding, Gao Ke Feng, and Xue Jun Jiang, “Changes of Naturally Occurring CD4+CD25+ FOXP3+ Regulatory T Cells in Patients With Acute Coronary Syndrome and the Beneficial Effects of Atorvastatin Treatment,” International Heart Journal, vol. 56, no. 2, pp. 163–169, 2015.
- Valery Bochkov, Andreas W Schoenenberger, Olga Oskolkova, Ursula Toth, Johannes Stöckl, Otto Majdic, Armond Daci, Thérèse J Resink, Paul Erne, and Maria Philippova, “Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids,” Biomarkers in Medicine, 2016.
- Tatyana Zaporozhets, and Natalia Besednova, “Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system: review,” Pharmaceutical Biology, pp. 1–10, 2016.
- Dimitry A. Chistiakov, Alexander N. Orekhov, and Yuri V. Bobryshev, “Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells,” Immunobiology, 2016.